Background: Catheter Associated Urinary Tract Infections (CAUTI) and Central Line Associated Bloodstream Infections (CLABSI) carry a huge health care burden and is associated with increased length of stay and potential harm for the patient. There is an estimated total healthcare cost of $896 per infection for CAUTI and $45,814 per infection associated with CLABSI. The […]

Case Presentation: A 77-year-old male with chronic kidney disease and mitral valve prolapse with a history of Lyme disease and West Nile Virus presented with fevers, night sweats, chills, and fatigue for 3 weeks. The patient had been visiting family in Texas for one month but gradually started to notice his symptoms. A few weeks […]

Background: Tebipenem pivoxil hydrobromide (TBP-PI-HBr) is an orally bioavailable prodrug that is rapidly converted in plasma to the carbapenem, tebipenem. Tebipenem has in vitro activity against select multidrug-resistant Gram-negative pathogens, including fluoroquinolone-resistant and extended-spectrum ß-lactamase (ESBL)-producing Enterobacterales. TBP-PI-HBr is being developed in the United States as the first oral carbapenem for treatment of cUTI and […]

Case Presentation: A 52-year-old unvaccinated male with past medical history of asthma and uncontrolled obstructive sleep apnea presented to the ED ten days after receiving a diagnosis of COVID-19 with worsening dyspnea. He endorsed a cough, fever, chills, and non-bloody diarrhea, and denied chest pain, leg edema, and anosmia. His initial vitals were remarkable for an oxygen saturation of 65%. A CBC demonstrated leukopenia […]